INMB: SAPIRSTEIN JAMES discloses securities transactions

By AlphaYouPublished Sep 17, 2026Form 4

Stocks in this disclosure

Reported activity

SAPIRSTEIN JAMES

Reporting filer

SAPIRSTEIN JAMES reported Grant or award in Inmune Bio, Inc.: 100000 units of Stock Options (derivative), dated 2026-09-15. The full Form 4 contains 1 transaction entry.

Disclosed: Sep 17, 2026

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Stock Options (derivative)	SAPIRSTEIN JAMES	2026-09-15	A	Grant or award	100000	0	100,000	2 days	Filed terms security Title: Stock Options conversion Or Exercise Price: 2.33 transaction Date: 2026-09-15 deemed Execution Date: transaction Form Type: 4 transaction Code: A equity Swap Involved: 0 transaction Timeliness: transaction Shares: 100000 transaction Price Per Share: 0 transaction Acquired Disposed Code: A id: F1 expiration Date: 2036-09-14 underlying Security Title: Common Stock underlying Security Shares: 100000 shares Owned Following Transaction: 100000 direct Or Indirect Ownership: D

Stock Options (derivative)

Owner: SAPIRSTEIN JAMES
Date: 2026-09-15
Code: A
Action: Grant or award
Quantity: 100000
Price: 0
Following holdings: 100,000
Reporting delay: 2 days
Filed terms and references: Filed terms
security Title: Stock Options
conversion Or Exercise Price: 2.33
transaction Date: 2026-09-15
deemed Execution Date:
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 100000
transaction Price Per Share: 0
transaction Acquired Disposed Code: A
id: F1
expiration Date: 2036-09-14
underlying Security Title: Common Stock
underlying Security Shares: 100000
shares Owned Following Transaction: 100000
direct Or Indirect Ownership: D

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
SAPIRSTEIN JAMES: Director.
F1: Represent an initial award of options in consideration for the Reporting Person's service to the Board of Directors of INmune Bio, Inc. Granted pursuant to the Issuer's Third Amended and Restated 2021 Stock Incentive Plan. The options will vest in 36 equal installments over three (3) years (1/36 per month) beginning one month after the grant date until the option is 100% vested which shall occur on the three-year anniversary of the date of grant.

Original sources

SEC ownership filing

Prepared automatically from public filing data. Report a correction.

Security

Owner

Date

Code

Action

Quantity

Price

Following holdings

Reporting delay

Filed terms and references

Stock Options (derivative)

SAPIRSTEIN JAMES

2026-09-15

Grant or award

100000

100,000

2 days

Filed terms

security Title: Stock Options
conversion Or Exercise Price: 2.33
transaction Date: 2026-09-15
deemed Execution Date:
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 100000
transaction Price Per Share: 0
transaction Acquired Disposed Code: A
id: F1
expiration Date: 2036-09-14
underlying Security Title: Common Stock
underlying Security Shares: 100000
shares Owned Following Transaction: 100000
direct Or Indirect Ownership: D

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.

SAPIRSTEIN JAMES: Director.

F1: Represent an initial award of options in consideration for the Reporting Person's service to the Board of Directors of INmune Bio, Inc. Granted pursuant to the Issuer's Third Amended and Restated 2021 Stock Incentive Plan. The options will vest in 36 equal installments over three (3) years (1/36 per month) beginning one month after the grant date until the option is 100% vested which shall occur on the three-year anniversary of the date of grant.